(PARP) Inhibitors in Combination Therapy with Camptothecins or
(other than CRC) in IBD
(OG) Surgery
(NSABP) and Genomic Health, Inc. Announce Positive Results from
(Nov 9, 2015) Aging Institute FY2016 Pilot
(NCI) designated cancer center 35 , or is affiliated with an NCI
(NCCN Guidelines®) Venous Thromboembolic Disease
(NCCN Guidelines®) Uterine Neoplasms
(NCCN Guidelines®) Uterine Neoplasms
(NCCN Guidelines®) Thyroid Carcinoma
(NCCN Guidelines®) Rectal Cancer
(NCCN Guidelines®) Rectal Cancer
(NCCN Guidelines®) Prostate Cancer
(NCCN Guidelines®) Penile Cancer
(NCCN Guidelines®) Occult Primary (Cancer of Unknown Primary
(NCCN Guidelines®) Non-Small Cell Lung Cancer
(NCCN Guidelines®) Non-Small Cell Lung Cancer
(NCCN Guidelines®) Kidney Cancer
(NCCN Guidelines®) Kidney Cancer
(NCCN Guidelines®) Head and Neck Cancers
(NCCN Guidelines®) Distress Management